Before the development of cell culture as a production matrix, vaccines were exclusively derived from viruses grown in animal systems. Further research into the potential of viruses to grow in cultivated cells led to the use of cells from several mammalian and avian sources as production matrixes in vaccine research and development. The avian cell banks are suitable for the production of a variety of viruses and vectors, they can replace chicken embryo fibroblasts (CEF) as a substrate, or the cultivation of viruses in embryonated hen's eggs. In addition, these cell banks can be used for different other products, such as sources of animal proteins or even for food applications.
According to current regulations, Creative Bioarray provides comprehensive and detailed services for avian cell bank characterization to help our customers worldwide in the field of cell banks, which are well characterized and have been tested for sterility, mycoplasma, extraneous agents, tumorigenicity, etc. Rapid and accurate results will be delivered to assist customers in accessing the quality of cell banks as soon as possible.
As a pioneer in biosafety testing service, Creative Bioarray provides cost-effective, high-quality, and hassle-free services to our customers worldwide. We offer international testing methodologies for avian cell bank characterization. We provide our clients with direct access to our experts and prompt responses to their questions. If you are interested in our services or have any questions, please feel free to contact us or make an online inquiry.
Creative Bioarray is the world leading biological company whose mission focuses on the acquisition, authentication, production, and development of standard reference microbial strains, and cell lines.